Pound hits six-month highs against the euro Sterling rose to a six-month high versus the euro today amid optimism that a vaccine against Covid-19 would bolster the UK economy and shifting expectations for Brexit and negative interest rates. Business • 11 Nov 20
Pound hits six-month highs against the euro Sterling rose to a six-month high versus the euro today amid optimism that a vaccine against Covid-19 would bolster the UK economy and shifting expectations for Brexit and negative interest rates. Business • 11 Nov 20
Brazil halts trials of Chinese Covid-19 vaccine Brazil's health regulator has said it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an "adverse incident" involving a volunteer recipient. Coronavirus • 10 Nov 20
Brazil halts trials of Chinese Covid-19 vaccine Brazil's health regulator has said it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an "adverse incident" involving a volunteer recipient. Coronavirus • 10 Nov 20
World markets soar on coronavirus vaccine hopes World stock markets soared today on hopes of a coronavirus vaccine following successful trials by pharmaceutical company, Pfizer. Business • 09 Nov 20
World markets soar on coronavirus vaccine hopes World stock markets soared today on hopes of a coronavirus vaccine following successful trials by pharmaceutical company, Pfizer. Business • 09 Nov 20
Small chance Oxford vaccine will be ready by Christmas The University of Oxford hopes to present late-stage trial results on its Covid-19 vaccine candidate this year though its top scientific investigator cautioned it would still take some time for life to return to normal. Coronavirus • 04 Nov 20
Small chance Oxford vaccine will be ready by Christmas The University of Oxford hopes to present late-stage trial results on its Covid-19 vaccine candidate this year though its top scientific investigator cautioned it would still take some time for life to return to normal. Coronavirus • 04 Nov 20
Pfizer not yet ready to release Covid-19 vaccine data Drugmaker Pfizer said today it was not yet ready to release data from the late-stage trial of the Covid-19 vaccine it is developing with Germany's BioNTech. Business • 27 Oct 20
Pfizer not yet ready to release Covid-19 vaccine data Drugmaker Pfizer said today it was not yet ready to release data from the late-stage trial of the Covid-19 vaccine it is developing with Germany's BioNTech. Business • 27 Oct 20
AstraZeneca, J&J vaccine trials back on track in US Two major clinical trials for experimental Covid-19 vaccines got back on track in the US yesterday, providing a glimmer of hope as the number of cases skyrocket across the country. World • 24 Oct 20
AstraZeneca, J&J vaccine trials back on track in US Two major clinical trials for experimental Covid-19 vaccines got back on track in the US yesterday, providing a glimmer of hope as the number of cases skyrocket across the country. World • 24 Oct 20
Roche confirms 2020 outlook as Covid diagnostics surge The frantic global effort to test people for Covid-19 pushed Roche's diagnostics division to record revenue, helping the Swiss drugmaker offset declining drug sales and keeping it on track to meet full-year 2020 targets. Business • 15 Oct 20
Roche confirms 2020 outlook as Covid diagnostics surge The frantic global effort to test people for Covid-19 pushed Roche's diagnostics division to record revenue, helping the Swiss drugmaker offset declining drug sales and keeping it on track to meet full-year 2020 targets. Business • 15 Oct 20
Open Orphan wins new £4.3m challenge study deal Dublin-listed pharmaceutical company Open Orphan has announced a new £4.3m contract to conduct a human viral challenge study using one of its eight traditional challenge study models for another of the global top 10 vaccine companies. Business • 28 Sep 20
Open Orphan wins new £4.3m challenge study deal Dublin-listed pharmaceutical company Open Orphan has announced a new £4.3m contract to conduct a human viral challenge study using one of its eight traditional challenge study models for another of the global top 10 vaccine companies. Business • 28 Sep 20
EU enters final talks for BioNTech-Pfizer vaccine The European Commission said today it had entered final stage talks with BioNTech-Pfizer to purchase up to 300 million doses of a potential vaccine against Covid-19. Business • 09 Sep 20
EU enters final talks for BioNTech-Pfizer vaccine The European Commission said today it had entered final stage talks with BioNTech-Pfizer to purchase up to 300 million doses of a potential vaccine against Covid-19. Business • 09 Sep 20
AstraZeneca pauses vaccine trials over safety concern Trials of a Covid-19 vaccine under development by AstraZeneca and Oxford University have been put on hold owing to a reported side effect in a patient in the UK. Coronavirus • 09 Sep 20
AstraZeneca pauses vaccine trials over safety concern Trials of a Covid-19 vaccine under development by AstraZeneca and Oxford University have been put on hold owing to a reported side effect in a patient in the UK. Coronavirus • 09 Sep 20
Sanofi sees coronavirus vaccine priced below €10 A coronavirus vaccine that Sanofi is developing with GlaxoSmithKline is likely to be priced at less than €10 per shot if it is approved for use, Sanofi's chief in France has said. Business • 07 Sep 20
Sanofi sees coronavirus vaccine priced below €10 A coronavirus vaccine that Sanofi is developing with GlaxoSmithKline is likely to be priced at less than €10 per shot if it is approved for use, Sanofi's chief in France has said. Business • 07 Sep 20
AstraZeneca's Covid vaccine begins late-stage US study AstraZeneca said it has begun enrolling adults for a US-funded, 30,000-subject late-stage study of its high profile Covid-19 vaccine candidate. Business • 01 Sep 20
AstraZeneca's Covid vaccine begins late-stage US study AstraZeneca said it has begun enrolling adults for a US-funded, 30,000-subject late-stage study of its high profile Covid-19 vaccine candidate. Business • 01 Sep 20
AstraZeneca starts trial of COVID-19 antibody treatment AstraZeneca said today that it had begun testing an antibody-based treatment for the prevention and treatment of Covid-19, with the first participants dosed, adding to recent signs of progress on possible medical solutions to the disease. Business • 25 Aug 20
AstraZeneca starts trial of COVID-19 antibody treatment AstraZeneca said today that it had begun testing an antibody-based treatment for the prevention and treatment of Covid-19, with the first participants dosed, adding to recent signs of progress on possible medical solutions to the disease. Business • 25 Aug 20
EU concludes vaccine supply talks with Moderna Moderna has concluded advanced talks with the European Union to supply 80 million doses of its Covid-19 vaccine candidate, which is currently in late-stage testing. Business • 24 Aug 20
EU concludes vaccine supply talks with Moderna Moderna has concluded advanced talks with the European Union to supply 80 million doses of its Covid-19 vaccine candidate, which is currently in late-stage testing. Business • 24 Aug 20
Russia says medics to get Covid vaccine in two weeks Russia said the first batch of its Covid-19 vaccine would be ready for some medics within two weeks and rejected as "groundless" safety concerns aired by some experts over Moscow's rapid approval of the drug. Coronavirus • 12 Aug 20
Russia says medics to get Covid vaccine in two weeks Russia said the first batch of its Covid-19 vaccine would be ready for some medics within two weeks and rejected as "groundless" safety concerns aired by some experts over Moscow's rapid approval of the drug. Coronavirus • 12 Aug 20
WHO wants to review Russian vaccine safety data The World Health Organization said any WHO stamp of approval on a Covid-19 vaccine candidate would require a rigorous safety data review, after Russia announced it had approved a vaccine. Coronavirus • 11 Aug 20
WHO wants to review Russian vaccine safety data The World Health Organization said any WHO stamp of approval on a Covid-19 vaccine candidate would require a rigorous safety data review, after Russia announced it had approved a vaccine. Coronavirus • 11 Aug 20
UK agrees joint investment with vaccine company Valneva Britain has agreed a multi-million pound joint investment with French speciality vaccines company Valneva to upgrade a manufacturing facility and increase production capacity for a possible Covid-19 vaccine. Business • 05 Aug 20
UK agrees joint investment with vaccine company Valneva Britain has agreed a multi-million pound joint investment with French speciality vaccines company Valneva to upgrade a manufacturing facility and increase production capacity for a possible Covid-19 vaccine. Business • 05 Aug 20
GSK's quarterly profit misses as stockpiling eases GlaxoSmithKline fell short of quarterly expectations for profit today, as sales of its existing vaccines fell and stockpiling of pain and lung medication tapered as countries eased coronavirus-induced lockdowns. Business • 29 Jul 20
GSK's quarterly profit misses as stockpiling eases GlaxoSmithKline fell short of quarterly expectations for profit today, as sales of its existing vaccines fell and stockpiling of pain and lung medication tapered as countries eased coronavirus-induced lockdowns. Business • 29 Jul 20
US to pay Pfizer $1.95 billion for Covid-19 vaccines Pfizer and German biotech firm BioNTech will get $1.95 billion from the US government to produce and deliver 100 million doses of their Covud-19 vaccine candidate, the companies said today. Business • 22 Jul 20
US to pay Pfizer $1.95 billion for Covid-19 vaccines Pfizer and German biotech firm BioNTech will get $1.95 billion from the US government to produce and deliver 100 million doses of their Covud-19 vaccine candidate, the companies said today. Business • 22 Jul 20
Two coronavirus vaccines 'produce immune response' Two coronavirus vaccine candidates have proven safe for humans and produced strong immune reactions among patients involved in separate clinical trials, doctors have said. Coronavirus • 20 Jul 20
Two coronavirus vaccines 'produce immune response' Two coronavirus vaccine candidates have proven safe for humans and produced strong immune reactions among patients involved in separate clinical trials, doctors have said. Coronavirus • 20 Jul 20
BioNTech and Pfizer's Covid-19 vaccine shows potential A Covid-19 vaccine developed by German biotech firm BioNTech and US pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said today. Business • 01 Jul 20
BioNTech and Pfizer's Covid-19 vaccine shows potential A Covid-19 vaccine developed by German biotech firm BioNTech and US pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said today. Business • 01 Jul 20
France's Sanofi to cut 1,700 European jobs Pharmaceutical giant Sanofi said today that it would eliminate 1,700 European jobs, including 1,000 in France, as part of a cost-cutting drive announced last December. Business • 26 Jun 20
France's Sanofi to cut 1,700 European jobs Pharmaceutical giant Sanofi said today that it would eliminate 1,700 European jobs, including 1,000 in France, as part of a cost-cutting drive announced last December. Business • 26 Jun 20
Open Orphan develops challenge study model for vaccines Dublin listed pharmaceutical company Open Orphan has said it is developing the world's first challenge study model to test the effectiveness of a number of Covid-19 vaccines that are in development. Business • 24 Jun 20
Open Orphan develops challenge study model for vaccines Dublin listed pharmaceutical company Open Orphan has said it is developing the world's first challenge study model to test the effectiveness of a number of Covid-19 vaccines that are in development. Business • 24 Jun 20
GSK to make 1 billion doses of virus vaccine booster GlaxoSmithKline, the world's largest vaccine maker, has laid out plans to produce 1 billion doses of vaccine efficacy boosters for Covid-19 shots next year. Business • 28 May 20
GSK to make 1 billion doses of virus vaccine booster GlaxoSmithKline, the world's largest vaccine maker, has laid out plans to produce 1 billion doses of vaccine efficacy boosters for Covid-19 shots next year. Business • 28 May 20
AstraZeneca to make billion vaccine doses if tests work AstraZeneca expects to be able to deliver a billion doses of a possible Covid-19 vaccine this year and next if tests are successful, adding today that it should shortly get results of an early stage clinical trial. Business • 21 May 20
AstraZeneca to make billion vaccine doses if tests work AstraZeneca expects to be able to deliver a billion doses of a possible Covid-19 vaccine this year and next if tests are successful, adding today that it should shortly get results of an early stage clinical trial. Business • 21 May 20
